RSL3 increased oxidized membrane lipid levels, as measured by confocal and flow cytometry using the dye C11-BODIPY in CRC DTP cells compared to the parental cells, supporting the notion of increased susceptibility of CRC persister cells to ferroptosis after 5-FU or AZ628 treatment ( Figures 3G, H )
Buyers should look closely at manufacturing transparency, requesting certificates of analysis and confirming that batches are tested by independent labs rather than relying solely on internal claims
Written By: Pharmacally Medical News Desk Novo Nordisk A/S has secured US FDA approval for its oral formulation of Wegovy, marking the first oral GLP-1 receptor agonist approved in the US for chronic weight management
Australia Clinical research on AOD-9604 has explored its potential to reduce fat deposits, particularly in cases of obesity, without causing potential side effects on blood sugar levels, insulin sensitivity, or muscle growth